Mounjaro 5mg/0.5ml - 2s (Tirzepatide Injection) 5mg/0.5ml

Mounjaro 5mg/0.5ml - 2s is a dual GIP and GLP-1 receptor agonist used in the management of type 2 diabetes mellitus. It is indicated for:

• Type 2 Diabetes Mellitus: Improves glycemic control in adults and pediatric patients 10 years of age and older when used as an adjunct to diet and exercise.
• Weight Management: May be used for weight loss in patients with type 2 diabetes mellitus.

• Tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action enhances glucose-dependent insulin secretion, reduces glucagon release, slows gastric emptying, and promotes weight loss, thereby improving glycemic control in patients with type 2 diabetes mellitus.

Mounjaro 5mg/0.5ml - 2s may cause various side effects, which can be categorized as follows:

Common Side Effects

• Nausea
• Diarrhea
• Decreased appetite
• Vomiting
• Constipation
• Injection site reactions
• Fatigue
• Dizziness

Serious or Rare Side Effects

• Pancreatitis: Severe abdominal pain that may radiate to the back.
• Hypoglycemia: Low blood sugar, especially when used with other antidiabetic medications.
• Kidney problems: Dehydration leading to acute kidney injury.
• Allergic reactions: Swelling of the face, lips, tongue, or throat, difficulty breathing, severe rash, or itching.
• Thyroid tumors: Increased risk of medullary thyroid carcinoma (MTC) in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Mounjaro 5mg/0.5ml - 2s should be used with caution and certain precautions should be observed:

• Contraindications: Do not use in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Hypersensitivity: Do not use in patients allergic to tirzepatide or any of the ingredients.
• Pancreatitis: Discontinue use if severe abdominal pain occurs.
• Hypoglycemia: Monitor blood sugar levels, especially when used with other antidiabetic medications.
• Kidney problems: Ensure adequate hydration to prevent dehydration and kidney issues.
• Surgery: May increase the risk of food getting into the lungs during surgery or other procedures.
• Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Mounjaro 5mg/0.5ml - 2s may interact with other medications, which can be categorized as follows:

Major Interactions (Avoid)

• Insulin: Increased risk of hypoglycemia when used together.
• Sulfonylureas: Increased risk of hypoglycemia when used together.
• Other GLP-1 receptor agonists: Increased risk of gastrointestinal side effects and hypoglycemia.

Moderate Interactions (Monitor Closely)

• Oral medications: May affect the absorption of oral medications due to delayed gastric emptying.
• Warfarin: May require monitoring of coagulation parameters due to potential changes in warfarin effectiveness.
• Oral contraceptives: May affect the effectiveness of oral contraceptives due to delayed gastric emptying.